Token is not live yet. Please beware of scams.
9.6 C
New York

Informed Choice – Compass

Date:

Node: 188245

Studies

Study First Submitted Date 2022-01-24
Study First Posted Date 2022-02-18
Last Update Posted Date 2023-02-01
Start Month Year April 28, 2022
Primary Completion Month Year March 2029
Verification Month Year January 2023
Verification Date 2023-01-31
Last Update Posted Date 2023-02-01

Detailed Descriptions

Sequence: 20781683
Description Subjects 45 to 70 years of age, scheduled for a primary care (index) appointment, at average risk for colorectal cancer (CRC), and due for CRC screening will be enrolled in the study. Subjects will be randomized to one of three intervention arms: no video (arm 1), brief CRC screening video (arm 2), or enhanced CRC screening video (arm 3). Subjects in all intervention arms will complete surveys regarding intention to screen for CRC and preference for screening modality prior to viewing the video, after the video, and after their index appointment. Subjects will be surveyed, and medical information collected, annually for up to six years to assess adherence to CRC screening and CRC screening outcomes.

Facilities

Sequence: 200602269 Sequence: 200602270 Sequence: 200602271 Sequence: 200602272 Sequence: 200602273 Sequence: 200602274 Sequence: 200602275 Sequence: 200602276 Sequence: 200602277 Sequence: 200602278 Sequence: 200602279 Sequence: 200602280 Sequence: 200602281 Sequence: 200602282 Sequence: 200602283 Sequence: 200602284 Sequence: 200602285 Sequence: 200602286 Sequence: 200602287 Sequence: 200602288 Sequence: 200602289 Sequence: 200602290 Sequence: 200602291
Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Recruiting Status Terminated Status Recruiting Status Recruiting Status Recruiting
Name Absolute Clinical Research Name Biopharma Informatic Name Saviers Medical Group Name Skylight Health Group Name Skylight Health Group Name I.V.A.M Clinical & Investigational Center Name ITB Research Name Emerald Coast OBGYN Name Pivotal Clinical Research & Associates, LLC Name Ascension DePaul Community Services of New Orleans Name Valley Ob-Gyn Clinic, PC Name Alliance Community Healthcare, INC Name North Hudson Community Action Corporation Name Niagara Falls Memorial Medical Center Name Skylight Health Name Center for Medical Research, LLC Name SPICA Clinical Research Name The Jackson Clinic, PA Name Clear Brook Medical Associates Name Family Practice Center Name BioPharma Informatic Name Valena Medical Research Name A & U Family Medicine
City Phoenix City Los Angeles City Port Hueneme City Aurora City Jacksonville City Miami City Miami City Panama City City Marietta City New Orleans City Saginaw City Jersey City City Union City City Niagara Falls City Harrisburg City Providence City Columbia City Jackson City Houston City McAllen City Pharr City Spring City Sugar Land
State Arizona State California State California State Colorado State Florida State Florida State Florida State Florida State Georgia State Louisiana State Michigan State New Jersey State New Jersey State New York State Pennsylvania State Rhode Island State South Carolina State Tennessee State Texas State Texas State Texas State Texas State Texas
Zip 85323 Zip 90035 Zip 93041 Zip 80012 Zip 32218 Zip 33144 Zip 33173 Zip 32405 Zip 30062 Zip 70118 Zip 48602 Zip 07302 Zip 07087 Zip 14304 Zip 17109 Zip 02908 Zip 29322 Zip 38305 Zip 77089 Zip 78501 Zip 78577 Zip 77379 Zip 77479
Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States Country United States

Facility Contacts

Sequence: 28184397 Sequence: 28184398 Sequence: 28184399 Sequence: 28184400 Sequence: 28184401 Sequence: 28184402 Sequence: 28184403 Sequence: 28184404 Sequence: 28184405 Sequence: 28184406 Sequence: 28184407 Sequence: 28184408 Sequence: 28184409 Sequence: 28184410 Sequence: 28184411 Sequence: 28184412 Sequence: 28184413 Sequence: 28184414 Sequence: 28184415 Sequence: 28184416 Sequence: 28184417 Sequence: 28184418
Facility Id 200602269 Facility Id 200602270 Facility Id 200602271 Facility Id 200602272 Facility Id 200602273 Facility Id 200602274 Facility Id 200602275 Facility Id 200602276 Facility Id 200602277 Facility Id 200602278 Facility Id 200602279 Facility Id 200602280 Facility Id 200602281 Facility Id 200602282 Facility Id 200602283 Facility Id 200602284 Facility Id 200602285 Facility Id 200602286 Facility Id 200602287 Facility Id 200602289 Facility Id 200602290 Facility Id 200602291
Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary Contact Type primary
Name Bianca Garcia Name Delmy Cordova Name Eugene Soroka, MD Name Wolfgang Williamson Name Kierra Johnson Name Alfredo Martin Cruz Name Vivianne Zerquera Name Lauren Green Name Willisha Johnson Name Ascension DePaul Services Research Office Name Rachel Whitney Name Jose Flores Name Jose Flores Name Erika Barba Name Bonni Conrad Name Shayna Smith Name Lari Powell Name Kelly Croom Name Ashly Abraham Name Alberto Ayala Name Jorge Rodriguez Name Cecilia Valerio
Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected] Email [email protected]
Phone 281-944-3610 Phone 805-271-0708 Phone 720-316-5601 Phone 904-701-2124 Phone 404-838-3105 Phone 504-582-0710 Phone 737-236-4830 Phone 717-219-8279 Phone 401-821-3200 Phone 281-944-3610

Facility Investigators

Sequence: 18378814 Sequence: 18378815 Sequence: 18378816 Sequence: 18378817 Sequence: 18378818 Sequence: 18378819 Sequence: 18378820 Sequence: 18378821 Sequence: 18378822 Sequence: 18378823 Sequence: 18378824 Sequence: 18378825 Sequence: 18378826 Sequence: 18378827 Sequence: 18378828 Sequence: 18378829 Sequence: 18378830 Sequence: 18378831 Sequence: 18378832 Sequence: 18378833 Sequence: 18378834 Sequence: 18378835
Facility Id 200602269 Facility Id 200602270 Facility Id 200602271 Facility Id 200602272 Facility Id 200602273 Facility Id 200602274 Facility Id 200602275 Facility Id 200602276 Facility Id 200602277 Facility Id 200602278 Facility Id 200602279 Facility Id 200602280 Facility Id 200602281 Facility Id 200602282 Facility Id 200602283 Facility Id 200602284 Facility Id 200602285 Facility Id 200602286 Facility Id 200602287 Facility Id 200602289 Facility Id 200602290 Facility Id 200602291
Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator Role Principal Investigator
Name James Beach, DO Name Samuel Ross, MD Name Eugene Soroka, MD Name Marion Hufford, FNP-C Name Allen Okie, MD Name Maria del Carmen Curbelo Calleiro, MD Name Antonio Gordon, MD Name Samuel Wolf, DO Name Melinda Miller-Thrasher, MD Name Stacy Greene, MD Name Jacquelyn Robinson, MD Name Mansi Sarvaiya, MD Name Rita Knause, MD Name Jeffrey Burnett, DO Name Richard Rayner, MD Name Gregory Allen, MD Name Damon Daniels, MD Name Kellie Wallace-Wilding, MD Name Jawad Sarwar, MD Name Omar Gomez, MD Name Pablo Amador, MD Name Hammad Zaidi, MD

Conditions

Sequence: 52324635
Name Colorectal Cancer
Downcase Name colorectal cancer

Id Information

Sequence: 40268481
Id Source org_study_id
Id Value 2019-02

Countries

Sequence: 42687952
Name United States
Removed False

Design Groups

Sequence: 55764184 Sequence: 55764185 Sequence: 55764186
Title Arm 1 – Usual Care (No Video) Title Arm 2 – Brief Video Title Arm 3 – Brief Video Plus
Description Subjects will receive the usual care pertaining to colorectal cancer (CRC) screening according to their respective clinical site and will not view either of the study videos. Description Subjects will watch a video pertaining to the importance of CRC screening. Description Subjects will watch the same video as described in Arm 2, immediately followed by a second video pertaining to 3 CRC screening modalities: colonoscopy, FIT, and Cologuard.

Interventions

Sequence: 52635718 Sequence: 52635719
Intervention Type Behavioral Intervention Type Behavioral
Name Brief Video Name Brief Video Plus
Description Videos about colorectal cancer screening. Description Videos about colorectal cancer screening and modalities.

Keywords

Sequence: 80080490 Sequence: 80080491 Sequence: 80080492 Sequence: 80080493 Sequence: 80080494 Sequence: 80080495 Sequence: 80080496 Sequence: 80080497
Name CRC Screening Name Colonoscopy Name FIT Name Cologuard Name Screening Modality Name Survey Name Video Name sDNA-FIT
Downcase Name crc screening Downcase Name colonoscopy Downcase Name fit Downcase Name cologuard Downcase Name screening modality Downcase Name survey Downcase Name video Downcase Name sdna-fit

Design Outcomes

Sequence: 177946048 Sequence: 177946049 Sequence: 177946050
Outcome Type primary Outcome Type primary Outcome Type primary
Measure Impact of Brief Videos Measure Impact of Brief Videos Measure Impact of Brief Videos
Time Frame 1 year Time Frame 3 years Time Frame 6 years
Description The percentage of time that subjects are colorectal cancer screening guideline adherent based on recommended screening interval for chosen method from the time of the index appointment to 1 year. Description The percentage of time that subjects are colorectal cancer screening guideline adherent based on recommended screening interval for chosen method from the time of the index appointment to 3 years. Description The percentage of time that subjects are colorectal cancer screening guideline adherent based on recommended screening interval for chosen method from the time of the index appointment to 6 years.

Browse Conditions

Sequence: 194071359 Sequence: 194071360 Sequence: 194071361 Sequence: 194071362 Sequence: 194071363 Sequence: 194071364 Sequence: 194071365 Sequence: 194071366 Sequence: 194071367 Sequence: 194071368 Sequence: 194071369
Mesh Term Colorectal Neoplasms Mesh Term Intestinal Neoplasms Mesh Term Gastrointestinal Neoplasms Mesh Term Digestive System Neoplasms Mesh Term Neoplasms by Site Mesh Term Neoplasms Mesh Term Digestive System Diseases Mesh Term Gastrointestinal Diseases Mesh Term Colonic Diseases Mesh Term Intestinal Diseases Mesh Term Rectal Diseases
Downcase Mesh Term colorectal neoplasms Downcase Mesh Term intestinal neoplasms Downcase Mesh Term gastrointestinal neoplasms Downcase Mesh Term digestive system neoplasms Downcase Mesh Term neoplasms by site Downcase Mesh Term neoplasms Downcase Mesh Term digestive system diseases Downcase Mesh Term gastrointestinal diseases Downcase Mesh Term colonic diseases Downcase Mesh Term intestinal diseases Downcase Mesh Term rectal diseases
Mesh Type mesh-list Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor

Sponsors

Sequence: 48463162 Sequence: 48463163 Sequence: 48463164 Sequence: 48463165 Sequence: 48463166
Agency Class INDUSTRY Agency Class OTHER Agency Class OTHER Agency Class OTHER Agency Class UNKNOWN
Lead Or Collaborator lead Lead Or Collaborator collaborator Lead Or Collaborator collaborator Lead Or Collaborator collaborator Lead Or Collaborator collaborator
Name Exact Sciences Corporation Name Mayo Clinic Name University of Utah Name American Cancer Society, Inc. Name F!ght Colorectal Cancer

Overall Officials

Sequence: 29367090 Sequence: 29367091 Sequence: 29367092
Role Principal Investigator Role Principal Investigator Role Principal Investigator
Name Joan M. Griffin, PhD Name John Inadomi, MD Name Charles R. Rogers, PhD
Affiliation Mayo Clinic College of Medicine Affiliation University of Utah Affiliation Rogers Solutions Group

Central Contacts

Sequence: 12047004
Contact Type primary
Name Haley Bowser
Phone 608-381-8118
Email [email protected]
Role Contact

Design Group Interventions

Sequence: 68356559 Sequence: 68356560
Design Group Id 55764185 Design Group Id 55764186
Intervention Id 52635718 Intervention Id 52635719

Eligibilities

Sequence: 30854343
Sampling Method Probability Sample
Gender All
Minimum Age 45 Years
Maximum Age 70 Years
Healthy Volunteers Accepts Healthy Volunteers
Population Subjects will be 45 to 70 years of age, inclusive, who are scheduled for a primary care appointment, at average risk for colorectal cancer (CRC), and due for CRC screening. The study will enroll approximately 5,280 subjects.
Criteria Inclusion Criteria: Subject is 45 to 70 years of age, inclusive. Subject presents for a primary care appointment. Subject understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information (PHI) to the study Investigator. Exclusion Criteria: Subject has symptoms or signs that require immediate, or near term referral for diagnostic or therapeutic colonoscopy. Subject has a personal history of colorectal cancer (CRC) or colonic adenomatous or sessile serrated polyps. Subject has a personal history of inflammatory bowel disease. Subject has a family history of CRC in at least one first- or second-degree relative diagnosed prior to age 60 and/or at least 2 first-degree relatives diagnosed with CRC at any age. Subject has a personal diagnosis or family history of any of the following conditions: Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP and Gardner's syndrome), Hereditary non-polyposis CRC syndrome (also referred to as "HNPCC" or "Lynch Syndrome"), Other hereditary cancer syndromes including, but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis, or Familial Hyperplastic Polyposis. Subject has a diagnosis of Cronkhite-Canada Syndrome Subject is current with CRC screening, including gFOBT or FIT within the preceding 12 months, Cologuard within the preceding 3 years, flexible sigmoidoscopy or CT colonography within the preceding 5 years, or colonoscopy within the preceding 10 years. Subjects can be enrolled up to 3 months prior to screening due date. Subject has any condition that in the opinion of the Investigator should preclude participation in the study, including comorbid illnesses precluding endoscopic evaluation or that limit life expectancy to less than 10 years.
Adult True
Child False
Older Adult True

Calculated Values

Sequence: 254310844
Number Of Facilities 23
Registered In Calendar Year 2022
Were Results Reported False
Has Us Facility True
Has Single Facility False
Minimum Age Num 45
Maximum Age Num 70
Minimum Age Unit Years
Maximum Age Unit Years
Number Of Primary Outcomes To Measure 3

Designs

Sequence: 30600187
Observational Model Cohort
Time Perspective Prospective

Responsible Parties

Sequence: 28966690
Responsible Party Type Sponsor

Study References

Sequence: 52229262
Pmid 35842109
Reference Type derived
Citation Griffin JM, Finney Rutten LJ, Zhu X, Feng Z, Rogers CR, Marsh TL, Inadomi JM. The COMPASS study: A prospective, randomized, multi-center trial testing the impact of a clinic-based intervention informing patients of colorectal cancer screening options on screening completion. Contemp Clin Trials. 2022 Aug;119:106852. doi: 10.1016/j.cct.2022.106852. Epub 2022 Jul 13.

Ipd Information Types

Sequence: 3346288 Sequence: 3346289 Sequence: 3346290 Sequence: 3346291
Name Study Protocol Name Statistical Analysis Plan (SAP) Name Informed Consent Form (ICF) Name Clinical Study Report (CSR)